Introducing Biomark™ X
an intuitive and transformative
real-time PCR platform

The neXT evolution in cytometry
has arrived.
The new CyTOF XT.

Celebrating over 1000 published
discoveries - and counting!

COVID-19 Update
Fluidigm's research and response
to the pandemic

Fluidigm正式更名为Standard BioTools Inc.

当您致力于新药研发以改善人类健康时
我们致力于开发更好更可靠的产品，以期为您提供更完善的解决方案

隆重向您介绍Standard BioTools，我们向您-科研界的先锋-郑重承诺
我们将全力以赴，依托先进技术及产品，助力生命科学行业更快、更好地开发突破性药物

Deliver new insights in health and disease

Fluidigm 多组学解决方案为您带来审视健康与疾病的全面新方法
无论您是寻求在癌症和免疫系统方面获得新发现，或是识别有意义的生物标志物，还是推进治疗方案开发进程，
我们都能助您实现目标。

微信图片_20201116120801.png 链接1 链接2 链接3 链接4

成功案例

倾听用户心声，分享成功体验，激发更多灵感

Enabling better insight

Dr. Xianting Ding on High-dimensional single-cell analysis enhances precision medicine

了解详情
Extending global understanding of COVID-19

Dr. Dexi Chen on Achieving multi-omic insights with microfluidics and CYTOF technology

了解详情
Cancer, autoimmunity and COVID-19

Using Imaging Mass Cytometry to define the diversity within cell response

了解详情

CyTOF^® XT^TM 下一代质谱流式系统

CyTOF^® XT™ 是Fluidigm旗下新一代质谱流式系统，新增样本自动上样采集功能，并配备内部监控系统。操作流程简便，安装成本低，是深入探索免疫复杂性更可靠、更全面的工具，为功能研究的优化和疾病管理的个性化提供助力。

Maxpar^® Direct™一站式免疫分型系统包含 Maxpar^® Direct™免疫
分型试剂盒及 Maxpar Pathsetter™ 软件，为人体PBMC及全血多参
数免疫分型提供 "sample-to-answer" 一站式分析的完整解决方案，
应用于 Helios™ 质谱流式系统即可轻松量化37种免疫细胞亚群组成。
简便的单管流程设计，仅需五分钟即可自动化完成分析及数据报告
输出。

了解详情

媒体摘要

“We are excited to recognize Fluidigm as the Company to Watch in 2019”

Craig Overpeck, CEO of Bioinformatics

媒体摘要

“Fluidigm mass cytometry is an advanced tool for high-content immune monitoring,
providing a wealth of information from each sample.”

Martin LeBlanc, President and CEO of Caprion Biosciences

媒体摘要

“C1 REAP-seq offers a new paradigm to accelerate the identification of
actionable biomarkers and drug targets.”

Carsten Krieg, PhD, Single Cell Analytics LLC

新闻动态

· Fluidigm 正式更名为 Standard BioTools Inc.

· Fluidigm中国上海办公室开启线上办公！

· 【专题】Fluidigm多组学解决方案，与您共同探讨传染病研究

· Fluidigm Biomark™ X 荣膺2021生命科学十大创新产品！

· Fluidigm中国抗体大促！

· 一机多能，业界翘楚– Fluidigm Biomark™ X 闪亮上市！

请提供您的联系方式：

姓 *
名 *
邮箱 *
公司 *
国家 *
电话
	我希望通过电话、电子邮件或其他电子方式接收Fluidigm产品和服务的信息
	同意服务条款和隐私政策

加入我们

我们热切期待与优秀的您一起迎接挑战，
共创辉煌

了解详情

联系我们

富鲁达（上海）仪器科技有限公司: 上海市中山西路1600号宏汇国际广场A座1709室; 邮编：200235; Tel：021-32558368 | Fax：021-32558369; Email：info-china@fluidigm.com; fluidigm.com.cn

沪ICP备16028619号-2

沪公网安备31010402008187号

访问统计：767372

Enabling better insight Dr. Xianting Ding on High-dimensional single-cell analysis enhances precision medicine

Extending global understanding of COVID-19 Dr. Dexi Chen on Achieving multi-omic insights with microfluidics and CYTOF technology

Cancer, autoimmunity and COVID-19 Using Imaging Mass Cytometry to define the diversity within cell response

Introducing Biomark™ Xan intuitive and transformative real-time PCR platform

The neXT evolution in cytometryhas arrived.The new CyTOF XT.

Celebrating over 1000 publisheddiscoveries - and counting!

COVID-19 UpdateFluidigm's research and responseto the pandemic

Fluidigm正式更名为Standard BioTools Inc.

Deliver new insights in health and disease

倾听用户心声，分享成功体验，激发更多灵感

Enabling better insight

Dr. Xianting Ding on High-dimensional single-cell analysis enhances precision medicine

Extending global understanding of COVID-19

Dr. Dexi Chen on Achieving multi-omic insights with microfluidics and CYTOF technology

Cancer, autoimmunity and COVID-19

Using Imaging Mass Cytometry to define the diversity within cell response

Craig Overpeck, CEO of Bioinformatics

Martin LeBlanc, President and CEO of Caprion Biosciences

Carsten Krieg, PhD, Single Cell Analytics LLC

新闻动态

市场活动

即将举行：

往期活动：

在线讲座

即将举行：

往期活动：

文献解读

蛋白组学

资料下载

资料下载：

请提供您的联系方式：

Introducing Biomark™ X
an intuitive and transformative
real-time PCR platform

The neXT evolution in cytometry
has arrived.
The new CyTOF XT.

Celebrating over 1000 published
discoveries - and counting!

COVID-19 Update
Fluidigm's research and response
to the pandemic